Literature DB >> 4594122

Long-term oral administration of probucol (4,4'-(isopropylidenedithio) bis(2,6-di-t-butylphenol)) (DH-581) in the management of hypercholesterolemia.

R S Harris, H R Gilmore, L A Bricker, I M Kiem, E Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4594122     DOI： 10.1111/j.1532-5415.1974.tb02163.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  6 in total

Review 1.  Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

2.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

Authors:  T Kita; Y Nagano; M Yokode; K Ishii; N Kume; A Ooshima; H Yoshida; C Kawai
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 3.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

4.  An overview of the biochemical pharmacology of probucol.

Authors:  J W Barnhart; D J Rytter; J A Molello
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

5.  Successful treatment of diffuse normolipemic plane xanthoma with probucol.

Authors:  Fumi Miyagawa; Takaya Fukumoto; Nobuhiko Kobayashi; Hideo Asada
Journal:  Case Rep Dermatol       Date:  2013-05-18

Review 6.  Xanthelasma: An Update on Treatment Modalities.

Authors:  Zainab Laftah; Firas Al-Niaimi
Journal:  J Cutan Aesthet Surg       Date:  2018 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.